FYI - in case someone here uses these:
Contraceptive Recalled For Out-Of-Order Pills
Dosage May Increase Pregnancy Risk
Women who take Nortrel 7/7/7 birth control pills should take a closer look at the tablets.
Barr Laboratories announced a voluntary recall of three lots -- or about 470,000 packages -- of the pills that might be improperly sequenced, which may increase the risk of pregnancy. The recall comes after two women contacted the company, saying their pills were out of order.
Nortrel 7/7/7 -- 28 day is packaged in a blister card containing four horizontal rows of seven tablets each, with each row representing one week of tablets. The top row should contain yellow tablets. The second row should contain blue tablets, and third row should contain peach tablets. The bottom row should contain white tablets. The colored tablets contain the active hormonal ingredients, while the white tablets are placebos that contain no active ingredient.
Women who take the product are urged to examine their blister cards to make sure they're in the right sequence. Women who take the pills in the wrong sequence could be at an increased risk of pregnancy, as well as changes to the menstrual cycle, including delayed bleeding, irregular bleeding or spotting.
The recall, which is effective immediately, involves lot numbers 290122001, 290122002 and 290122003. The lot numbers should appear in a window labeled "LOT:" on the upper right-hand corner of the back side of the package. Any Nortrel 7/7/7 28-day product that does not have a lot number in that location is also subject to the recall.
If women find that their blister cards contain out-of-sequence tablets, they should continue taking the product, immediately consult with their health care practitioner for further instructions and return the product to their pharmacist for a replacement blister card.
The company will replace any out-of-sequence blister card for free and will also cover the cost of a pregnancy test for any woman who purchased and used a blister card with out-of-sequence tablets.
Doctors, pharmacists or women seeking additional information on this recall are encouraged to call Barr Laboratories Inc.'s Drug Information at 800-222-0190 extension 33302.
Copyright © 2012
Time Inc. Lifestyle Group.
All Rights Reserved. Use of this site constitutes acceptance of our
Your California Privacy Rights).